[Heartburn and regurgitation in pregnancy. Efficacy and innocuousness of treatment with Gaviscon suspension]
- PMID: 2848305
[Heartburn and regurgitation in pregnancy. Efficacy and innocuousness of treatment with Gaviscon suspension]
Abstract
This open trial was conducted in 50 pregnant women, presenting during the 2nd and 3rd trimesters of their pregnancy typical symptoms of gastro-esophageal reflux (pyrosis, regurgitations, retro-sternal burning sensations, dyspepsia, epigastric burning). The treatment with Gaviscon, suspension to drink, lasted 1 month at a dose of 2 tablespoons, 4 times/day after meals and in the evening at bedtime. After one month, all symptoms were improved, in a statistically significant fashion, regarding their frequency, intensity and duration. The efficacy is considered positive in 98 p. cent of the cases; the patient's impression is favorable in 70 p. cent of the cases. Tolerance is excellent and the medication is satisfactorily accepted.
Similar articles
-
[Treatment of gastro-esophageal reflux using a potable gaviscon suspension].Med Chir Dig. 1982;11(4):289-95. Med Chir Dig. 1982. PMID: 6287126 Clinical Trial. French. No abstract available.
-
Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.Br J Clin Pract Suppl. 1989 Feb;66:52-5; discussion 61-4. Br J Clin Pract Suppl. 1989. PMID: 2556176 Clinical Trial. No abstract available.
-
An open-label, multicentre study to assess the safety and efficacy of a novel reflux suppressant (Gaviscon Advance) in the treatment of heartburn during pregnancy.Int J Clin Pract. 2003 Apr;57(3):175-9. Int J Clin Pract. 2003. PMID: 12723718 Clinical Trial.
-
[Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].Eksp Klin Gastroenterol. 2008;(4):64-77. Eksp Klin Gastroenterol. 2008. PMID: 19145905 Review. Russian. No abstract available.
-
Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.Aliment Pharmacol Ther. 2000 Jun;14(6):669-90. doi: 10.1046/j.1365-2036.2000.00759.x. Aliment Pharmacol Ther. 2000. PMID: 10848650 Review.
Cited by
-
Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy.ISRN Obstet Gynecol. 2012;2012:481870. doi: 10.5402/2012/481870. Epub 2012 Nov 4. ISRN Obstet Gynecol. 2012. PMID: 23209926 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical